Login to Your Account



GSK's Witty calls on pharma to embrace change, take more risks

By Michael Fitzhugh
Staff Writer

Thursday, March 17, 2016

Announcing his plans to retire as CEO of Glaxosmithkline plc with a call to arms, industry provocateur Andrew Witty rallied a Washington think tank audience Thursday to pursue greater industry modernization, transparency and action.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription